Old Web
English
Sign In
Acemap
>
authorDetail
>
F. Javier Escalada
F. Javier Escalada
University of Navarra
Medicine
Diabetes mellitus
Internal medicine
Renal function
Insulin glargine
4
Papers
58
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Insulin glargine 300 lowers the risk of hypoglycemia in people with type 2 diabetes and mild-to-moderate renal impairment
2019
F. Javier Escalada
Serge Halimi
Peter A. Senior
Mireille Bonnemaire
Anna M. G. Cali
Lydie Melas-Melt
Janaka Karalliedde
Robert Ritzel
Show All
Source
Cite
Save
Citations (0)
SP453MATRIX METALLOPROTEINASE-10 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 (TIMP-1) AS EARLY PREDICTORS OF NEPHROPATHY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
2018
Nephrology Dialysis Transplantation
Jose María Mora Gutierrez
María A. Fernández-Seara
M.ª Fernanda Slon Roblero
Omar Jose González
F. Javier Escalada
María José Soler
José A. Páramo
Nuria Garcia-Fernandez
Show All
Source
Cite
Save
Citations (0)
Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild‐to‐moderate renal impairment
2018
Diabetes, Obesity and Metabolism
F. Javier Escalada
S. Halimi
Peter A. Senior
Mireille Bonnemaire
Anna M. G. Cali
Lydie Melas‐Melt
Janaka Karalliedde
Robert Ritzel
Show All
Source
Cite
Save
Citations (11)
Arterial spin labeling MRI is able to detect early hemodynamic changes in diabetic nephropathy
2017
Journal of Magnetic Resonance Imaging
Jose María Mora Gutierrez
Nuria Garcia-Fernandez
M.ª Fernanda Slon Roblero
José A. Páramo
F. Javier Escalada
Danny J.J. Wang
Alberto Benito
María A. Fernández-Seara
Show All
Source
Cite
Save
Citations (47)
1